These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31336553)

  • 21. The metabolic consequences of overweight in a cohort of children with type 1 diabetes.
    Sevaliev N; Strich D; Avnon-Ziv C; Levy-Khademi F
    J Pediatr Endocrinol Metab; 2019 Jul; 32(7):715-719. PubMed ID: 31150359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum Ferritin level, microalbuminuria and non-alcoholic fatty liver disease in type 2 diabetic patients.
    Amin RF; El Bendary AS; Ezzat SE; Mohamed WS
    Diabetes Metab Syndr; 2019; 13(3):2226-2229. PubMed ID: 31235161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
    Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK
    Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical and genetic characteristics of familial hypercholesterolemia patients with type 2 diabetes.
    Sun D; Cao YX; You XD; Zhou BY; Li S; Guo YL; Zhang Y; Wu NQ; Zhu CG; Gao Y; Dong QT; Liu G; Dong Q; Li JJ
    J Endocrinol Invest; 2019 May; 42(5):591-598. PubMed ID: 30276670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Gaddi A; Ciccarelli L; Piccinni MN; Salvadeo SA; Pricolo F; Ferrari I; Gravina A; Ragonesi PD
    Clin Ther; 2006 May; 28(5):679-88. PubMed ID: 16861090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of Ramadan fasting on metabolic profile among type 2 diabetes mellitus patients: A meta-analysis.
    Tahapary DL; Astrella C; Kristanti M; Harbuwono DS; Soewondo P
    Diabetes Metab Syndr; 2020; 14(5):1559-1570. PubMed ID: 32947756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes?
    Osei K; Rhinesmith S; Gaillard T; Schuster D
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4596-601. PubMed ID: 14557428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between lipids and apolipoproteins on type 2 diabetes risk; moderating effects of gender and polymorphisms; the ATTICA study.
    Mellor DD; Georgousopoulou EN; D'Cunha NM; Naumovski N; Chrysohoou C; Tousoulis D; Pitsavos C; Panagiotakos DB;
    Nutr Metab Cardiovasc Dis; 2020 May; 30(5):788-795. PubMed ID: 32127339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
    Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G
    Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-sectional study of the determinants and associations of sex hormone-binding globulin concentrations in first degree relatives (FDR) of patients with Type 2 Diabetes Mellitus.
    Abdella NA; Mojiminiyi OA
    Diabetes Res Clin Pract; 2017 Nov; 133():159-167. PubMed ID: 28950181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome.
    Nauck MA; Meier JJ; Wolfersdorff AV; Tillil H; Creutzfeldt W; Köbberling J
    Acta Diabetol; 2003 Dec; 40(4):163-72. PubMed ID: 14740275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.
    Lau CH; Muniandy S
    Cardiovasc Diabetol; 2011 Jan; 10():8. PubMed ID: 21251282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 2 diabetes mellitus unawareness, prevalence, trends and risk factors: National Health and Nutrition Examination Survey (NHANES) 1999-2010.
    Zhang N; Yang X; Zhu X; Zhao B; Huang T; Ji Q
    J Int Med Res; 2017 Apr; 45(2):594-609. PubMed ID: 28415936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic control and cardiovascular risk factors in type 2 diabetes mellitus patients according to diabetes duration.
    Franch-Nadal J; Roura-Olmeda P; Benito-Badorrey B; Rodriguez-Poncelas A; Coll-de-Tuero G; Mata-Cases M;
    Fam Pract; 2015 Feb; 32(1):27-34. PubMed ID: 25194144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between brachial-ankle pulse wave velocity and glycemic control of type 2 diabetes mellitus patients in Beijing community population].
    Sun KX; Liu ZK; Cao YY; Juan J; Xiang X; Yang C; Huang SP; Liu XF; Li N; Tang X; Li J; Wu T; Chen DF; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Jun; 47(3):431-6. PubMed ID: 26080871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of ramadan fasting on glycemic control and other essential variables in diabetic patients.
    Bener A; A Al-Hamaq AOA; Öztürk M; Çatan F; Haris PI; Rajput KU; Ömer A
    Ann Afr Med; 2018; 17(4):196-202. PubMed ID: 30588933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signs of Deregulated Gene Expression Are Present in Both CD14
    Koc M; Šiklová M; Šrámková V; Štěpán M; Krauzová E; Štich V; Rossmeislová L
    Front Endocrinol (Lausanne); 2020; 11():582732. PubMed ID: 33658980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treat-to-target HbA
    Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
    Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome.
    Scuteri A; Tesauro M; Rizza S; Iantorno M; Federici M; Lauro D; Campia U; Turriziani M; Fusco A; Cocciolillo G; Lauro R
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):349-56. PubMed ID: 17935958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
    Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
    Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.